In a mouse model of breast cancer, the combination of IFN-γ and MPLA (Monophosphoryl Lipid A), a TLR4 ligand, results in the reduction of tumor growth and metastatic potential of cancer cells via reprogramming of TAMs into pro-inflammatory macrophages expressing TNFα and IL-12. This evidence concerns the gene IFNG and cancer.